0001209191-20-060665.txt : 20201127 0001209191-20-060665.hdr.sgml : 20201127 20201127200012 ACCESSION NUMBER: 0001209191-20-060665 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201125 FILED AS OF DATE: 20201127 DATE AS OF CHANGE: 20201127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FEES JESSICA CENTRAL INDEX KEY: 0001760391 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38459 FILM NUMBER: 201356109 MAIL ADDRESS: STREET 1: C/O SURFACE ONCOLOGY, ICN. STREET 2: 50 HAMPSHIRE STREET 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Surface Oncology, Inc. CENTRAL INDEX KEY: 0001718108 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 HAMPSHIRE STREET, 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-714-4096 MAIL ADDRESS: STREET 1: 50 HAMPSHIRE STREET, 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-25 0 0001718108 Surface Oncology, Inc. SURF 0001760391 FEES JESSICA C/O SURFACE ONCOLOGY, INC. 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 0 1 0 0 See Remarks Common Stock 2020-11-25 4 M 0 227 4.136 A 101027 D Common Stock 2020-11-25 4 M 0 173 4.27 A 101200 D Common Stock 2020-11-25 4 M 0 982 5.412 A 102182 D Common Stock 2020-11-25 4 M 0 1 4.27 A 102183 D Stock Option (Right to Buy) 4.136 2020-11-25 4 M 0 227 0.00 D 2026-12-09 Common Stock 227 455 D Stock Option (Right to Buy) 4.27 2020-11-25 4 M 0 173 0.00 D 2029-03-01 Common Stock 173 13905 D Stock Option (Right to Buy) 5.412 2020-11-25 4 M 0 982 0.00 D 2027-06-27 Common Stock 982 2654 D Stock Option (Right to Buy) 4.27 2020-11-25 4 M 0 1 0.00 D 2029-03-01 Common Stock 1 25999 D This option shall vest in 48 equal monthly installments after January 1, 2017. The stock option vests and becomes exercisable in 48 equal monthly installments after November 18, 2018. This option shall vest in 48 equal monthly installments after July 1, 2017. The stock option vests and becomes exercisable in 48 equal monthly installments after February 12, 2019. Title: Principal Accounting Officer, Principal Financial Officer /s/ Jessica Fees 2020-11-27